
OXIDINE MOUTHWASH Clinical Monograph & Batch COA
Certified DCGI Formulation Literature (PDF)
OXIDINE MOUTHWASH
Chlorhexidine Gluconate Solution 0.2% w/w
OXIDINE MOUTHWASH (Chlorhexidine Gluconate Solution 0.2% w/w) is manufactured under strict WHO-GMP compliance for maximum bioavailability and therapeutic efficacy.
Clinical Pharmacology & Therapeutic Profile
Comprehensive therapeutic guidelines for medical practitioners and institutional procurement
Therapeutic Indications
Mechanism of Action (MOA)
The active pharmacological principles in OXIDINE MOUTHWASH deliver targeted therapeutic action through standardized systemic bioavailability and verified pharmacodynamics.
As directed by the registered medical practitioner. Strictly adhere to full course duration.
Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.
Store below 25°C in a dry place. Protect from moisture and direct sunlight.
WHO-GMP Certified Purity
Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.
Alu-Alu Moisture Barrier
Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.
Exclusive District Monopoly
Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.
Technical Product Specifications
Active Medical Composition
OXIDINE MOUTHWASH features Chlorhexidine Gluconate Solution 0.2% w/w prepared to high pharmaceutical purity standards.
*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.
Customer & Clinical Reviews
Real feedback from registered physicians, stockists, PCD franchise partners, and verified buyers.
Based on 1 verified review
Endorsed by attending medical offic for OXIDINE MOUTHWASH
OXIDINE MOUTHWASH has been endorsed by attending medical officers for dependable recovery, offering predictable therapeutic action that doctors in our territory rely upon daily. Sturdy outer cartons and individual pack serialization facilitate seamless inventory scanning. Continues to be a key prescription driver in our PCD pharma franchise portfolio.
Questions Regarding OXIDINE MOUTHWASH
What is the therapeutic indication and composition of OXIDINE MOUTHWASH?
OXIDINE MOUTHWASH contains Chlorhexidine Gluconate Solution 0.2% w/w indicated for Indicated for therapeutic management within specified clinical indications under qualified physician guidance. as formulated by Sygnus Biotech.
What packaging presentations are available for OXIDINE MOUTHWASH?
OXIDINE MOUTHWASH is supplied in tamper-evident 10 x 10 Alu-Alu / Blister Pack, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.
Is monopoly PCD franchise territory available for OXIDINE MOUTHWASH?
Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for OXIDINE MOUTHWASH along with promotional visual aids, product cards, and marketing support.
What is the regulatory schedule and minimum order quantity (MOQ)?
OXIDINE MOUTHWASH is categorized as Schedule H with an introductory PCD franchise MOQ of 100 units per batch.





